Analyst action: Healthways, Delek

Analysts at Barclays Capital and Jefferies have lowered their price targets for two local companies. David Kaplan at Barclays reiterated his 'equal weight' rating on Delek (Ticker: DK) and lowered his target to $8 from $9. Similarly, Jefferies' Art Henderson still rates Healthways (Ticker: HWAY) a hold, but now sees it going to $10 instead of $12.